A so-called patent “thicket” is a collection of many patents with overlapping claims, usually from the same patent application family, covering a single product (and its variations). The use of patent “thickets” to protect drugs and biological products has been the subject of Congressional oversight into rising drug prices.1 As explained below,...
Salem, MA (Law Firm Newswire) May 03, 2022 – Capuano IP announced today that its new website, CapuanoIP.com, has been launched. Founded in 2020, the firm is a micro-boutique intellectual property practice that provides expert IP and litigation services to clients in the chemistry, pharmaceutical, and related life sciences.
Represented Dicerna in trade secret litigation regarding RNA interference technology. Settled before trial favorably for Dicerna.
Represented Dicerna in antitrust litigation with its competitor Alnylam in the RNA interference field. Settled favorably for Dicerna.
Representing Defendant Acrux in patent litigation over ANDA to make a generic version of Almirall’s topical acne product Aczone (dapsone). Pending.